Micah Mitchell Sells 48,000 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Micah Mitchell sold 48,000 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.16, for a total transaction of $247,680.00. Following the transaction, the insider now owns 140,572 shares of the company’s stock, valued at $725,351.52. This trade represents a 25.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Myomo Trading Up 2.4 %

MYO stock opened at $5.19 on Monday. The stock has a market capitalization of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68. Myomo, Inc. has a 12 month low of $2.51 and a 12 month high of $7.17.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC purchased a new position in Myomo during the 3rd quarter valued at about $36,000. BNP Paribas Financial Markets purchased a new position in Myomo during the 4th quarter valued at about $64,000. Jane Street Group LLC purchased a new position in Myomo during the 3rd quarter valued at about $65,000. Walleye Capital LLC purchased a new position in Myomo during the 4th quarter valued at about $66,000. Finally, Squarepoint Ops LLC purchased a new position in Myomo during the 4th quarter valued at about $74,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on MYO. Alliance Global Partners restated a “buy” rating on shares of Myomo in a report on Tuesday, March 11th. Craig Hallum raised their target price on shares of Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a report on Tuesday, March 11th. Finally, HC Wainwright raised their target price on shares of Myomo from $7.50 to $9.50 and gave the stock a “buy” rating in a report on Wednesday, March 12th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $9.25.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.